Biomaterials specialized company

ACE BIOPHARM

We have the solution you need

Report

Standard Balance Sheet (Dec. 2020)

(Unit: million won)

Current assets 30,917
Non-current assets 12,551
Total assets 43,468
Current liabilities 16,133
Non-current liabilities 10,789
Total liabilities 26,922
Capital 500
Retained earnings 16,046
Total equity 16,546

 

 

Standard Income Statement (2019)

(Unit: million won)

Sales 76,590
Cost of sales 65,452
Gross profit(loss) 11,138
Selling and administrative 9,245
Operating profit(loss) 1,893
Non-operating income 2,404
Non-operating expenses 1,170
Net income(loss)before income tax expenses 3,127
Income tax expenses 0.003
Net income(loss) 3,126

 

Sales Figures

[06784] 41, Dongsan-ro 8-gil, Seocho-gu, Seoul, Republic of Korea
CEO : Min-Byoung Gyu /  TEL : +82-2-579-1056  /  FAX : +82-2-6008-3356  /  E-mail : ace@acebiopharm.com

Copyright © 2010 ABP company. All Rights Reserved.